Jinxin Fertility Group Limited (HKG:1951)

Market Cap	8.51B
Revenue (ttm)	2.99B
Net Income (ttm)	301.27M
Shares Out	2.74B
EPS (ttm)	0.11
PE Ratio	29.13
Forward PE	17.43
Dividend	0.06 (1.92%)
Ex-Dividend Date	n/a

Volume	47,297,637
Average Volume	131,592,992
Open	3.100
Previous Close	3.100
Day's Range	3.020 - 3.160
52-Week Range	2.070 - 4.640
Beta	1.50
RSI	51.90
Earnings Date	Mar 28, 2025

About Jinxin Fertility Group

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, an...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1951
• Employees: 3,192
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1951

Financial Performance

In 2024, Jinxin Fertility Group's revenue was 2.81 billion, an increase of 0.81% compared to the previous year's 2.79 billion. Earnings were 283.10 million, a decrease of -17.88%.

Financial numbers in CNY